Gene Symbol | Gene ID | Gene Info |
---|---|---|
OLIG3
|
ENSG00000177468.5 | oligodendrocyte transcription factor 3 |
NEUROD2
|
ENSG00000171532.4 | neuronal differentiation 2 |
NEUROG2
|
ENSG00000178403.3 | neurogenin 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_37763275_37763426 | NEUROD2 | 846 | 0.506285 | -0.86 | 3.0e-03 | Click! |
chr17_37762654_37763013 | NEUROD2 | 1363 | 0.329936 | -0.72 | 3.0e-02 | Click! |
chr17_37753377_37753528 | NEUROD2 | 10744 | 0.133022 | -0.70 | 3.5e-02 | Click! |
chr17_37760337_37760488 | NEUROD2 | 3784 | 0.161988 | -0.67 | 4.9e-02 | Click! |
chr17_37763524_37763889 | NEUROD2 | 490 | 0.723270 | -0.66 | 5.4e-02 | Click! |
chr4_113437546_113438608 | NEUROG2 | 749 | 0.580790 | -0.79 | 1.2e-02 | Click! |
chr4_113444494_113444726 | NEUROG2 | 7282 | 0.194991 | -0.75 | 2.1e-02 | Click! |
chr4_113437034_113437317 | NEUROG2 | 153 | 0.857206 | -0.63 | 7.1e-02 | Click! |
chr4_113444021_113444357 | NEUROG2 | 6861 | 0.196728 | -0.56 | 1.1e-01 | Click! |
chr4_113445008_113445159 | NEUROG2 | 7755 | 0.193256 | -0.55 | 1.2e-01 | Click! |
chr6_137818816_137819005 | OLIG3 | 3379 | 0.327250 | -0.86 | 2.8e-03 | Click! |
chr6_137809840_137810059 | OLIG3 | 5582 | 0.291250 | -0.86 | 3.2e-03 | Click! |
chr6_137810748_137811158 | OLIG3 | 4578 | 0.303690 | -0.80 | 9.4e-03 | Click! |
chr6_137810179_137810330 | OLIG3 | 5277 | 0.294354 | -0.72 | 2.9e-02 | Click! |
chr6_137736493_137736696 | OLIG3 | 78937 | 0.105906 | -0.69 | 3.9e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_99299485_99299728 | 1.67 |
RAP1GDS1 |
RAP1, GTP-GDP dissociation stimulator 1 |
647 |
0.81 |
chr12_66009397_66009548 | 1.64 |
HMGA2 |
high mobility group AT-hook 2 |
208439 |
0.02 |
chr4_85672938_85673089 | 1.39 |
WDFY3 |
WD repeat and FYVE domain containing 3 |
18398 |
0.22 |
chr21_30563255_30563442 | 1.37 |
LINC00189 |
long intergenic non-protein coding RNA 189 |
2453 |
0.18 |
chr6_21402550_21402701 | 1.28 |
SOX4 |
SRY (sex determining region Y)-box 4 |
191347 |
0.03 |
chr18_400883_401133 | 1.27 |
RP11-720L2.2 |
|
23408 |
0.22 |
chr6_64514775_64515101 | 1.26 |
RP11-59D5__B.2 |
|
1791 |
0.5 |
chr2_237881937_237882226 | 1.25 |
ENSG00000202341 |
. |
41867 |
0.18 |
chr9_74361159_74361436 | 1.23 |
TMEM2 |
transmembrane protein 2 |
22005 |
0.26 |
chr19_18789164_18789362 | 1.19 |
CRTC1 |
CREB regulated transcription coactivator 1 |
5224 |
0.15 |
chr16_68826742_68826986 | 1.16 |
RP11-354M1.2 |
|
30565 |
0.13 |
chr12_91499723_91499874 | 1.15 |
LUM |
lumican |
5810 |
0.25 |
chr22_18155551_18155708 | 1.15 |
BCL2L13 |
BCL2-like 13 (apoptosis facilitator) |
17151 |
0.16 |
chr5_134769606_134770119 | 1.13 |
C5orf20 |
chromosome 5 open reading frame 20 |
13176 |
0.14 |
chr9_4886688_4886839 | 1.13 |
AL158147.2 |
HCG2011465; Uncharacterized protein |
27503 |
0.14 |
chr15_51602118_51602364 | 1.12 |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
8448 |
0.17 |
chr14_61088518_61088669 | 1.11 |
ENSG00000253014 |
. |
14808 |
0.2 |
chr3_152787726_152787975 | 1.10 |
RP11-529G21.2 |
|
91714 |
0.08 |
chr6_16742396_16742915 | 1.10 |
RP1-151F17.1 |
|
18714 |
0.23 |
chr3_55194963_55195234 | 1.09 |
LRTM1 |
leucine-rich repeats and transmembrane domains 1 |
193983 |
0.03 |
chr12_91367432_91367583 | 1.09 |
CCER1 |
coiled-coil glutamate-rich protein 1 |
18554 |
0.22 |
chr4_141085920_141086071 | 1.09 |
MAML3 |
mastermind-like 3 (Drosophila) |
10657 |
0.23 |
chr5_151057177_151057484 | 1.08 |
CTB-113P19.1 |
|
796 |
0.56 |
chr2_200247200_200247460 | 1.06 |
RP11-486F17.1 |
|
57297 |
0.14 |
chr1_66286156_66286307 | 1.06 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
27367 |
0.22 |
chr11_70172117_70172347 | 1.06 |
CTA-797E19.2 |
|
1083 |
0.38 |
chr8_24065173_24065324 | 1.05 |
ADAM28 |
ADAM metallopeptidase domain 28 |
86305 |
0.09 |
chr3_148367275_148367426 | 1.05 |
AGTR1 |
angiotensin II receptor, type 1 |
48221 |
0.18 |
chr17_27443100_27443626 | 1.05 |
MYO18A |
myosin XVIIIA |
24073 |
0.12 |
chr6_72443718_72443869 | 1.04 |
ENSG00000202069 |
. |
81479 |
0.1 |
chr2_145765415_145765691 | 1.03 |
ENSG00000253036 |
. |
327085 |
0.01 |
chrX_13269027_13269605 | 1.03 |
GS1-600G8.3 |
|
59455 |
0.14 |
chr13_32169275_32169426 | 1.02 |
RXFP2 |
relaxin/insulin-like family peptide receptor 2 |
144324 |
0.05 |
chr8_17508271_17508422 | 1.02 |
MTUS1 |
microtubule associated tumor suppressor 1 |
25492 |
0.16 |
chr2_197345751_197345902 | 1.01 |
HECW2 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 |
111509 |
0.06 |
chr18_74198201_74198352 | 1.01 |
ZNF516 |
zinc finger protein 516 |
4459 |
0.19 |
chr5_82672926_82673088 | 1.00 |
VCAN |
versican |
94277 |
0.09 |
chr20_36901732_36901938 | 0.99 |
KIAA1755 |
KIAA1755 |
12661 |
0.16 |
chr1_115876997_115877219 | 0.99 |
NGF |
nerve growth factor (beta polypeptide) |
3749 |
0.32 |
chr1_36581755_36582054 | 0.99 |
COL8A2 |
collagen, type VIII, alpha 2 |
8917 |
0.14 |
chr20_39134650_39134801 | 0.99 |
ENSG00000252434 |
. |
89210 |
0.1 |
chr18_57314477_57314628 | 0.98 |
CCBE1 |
collagen and calcium binding EGF domains 1 |
18842 |
0.19 |
chr6_57170948_57171315 | 0.98 |
PRIM2 |
primase, DNA, polypeptide 2 (58kDa) |
11291 |
0.25 |
chr15_39448730_39448881 | 0.98 |
RP11-624L4.1 |
|
37891 |
0.21 |
chr12_89453867_89454269 | 0.98 |
ENSG00000238302 |
. |
221994 |
0.02 |
chr7_41087768_41087919 | 0.97 |
AC005160.3 |
|
272686 |
0.02 |
chr6_17993158_17993663 | 0.96 |
KIF13A |
kinesin family member 13A |
5556 |
0.3 |
chr3_108123228_108123379 | 0.96 |
HHLA2 |
HERV-H LTR-associating 2 |
50800 |
0.15 |
chr5_53966243_53966648 | 0.96 |
SNX18 |
sorting nexin 18 |
152852 |
0.04 |
chr1_56184117_56184268 | 0.96 |
PIGQP1 |
phosphatidylinositol glycan anchor biosynthesis, class Q pseudogene 1 |
220761 |
0.02 |
chr8_12859880_12860031 | 0.96 |
ENSG00000206996 |
. |
41904 |
0.16 |
chr3_34052870_34053021 | 0.95 |
PDCD6IP |
programmed cell death 6 interacting protein |
212830 |
0.02 |
chrX_41157450_41157601 | 0.95 |
ENSG00000199564 |
. |
5474 |
0.19 |
chr13_21653241_21653392 | 0.95 |
LATS2 |
large tumor suppressor kinase 2 |
17630 |
0.14 |
chr17_48263861_48264012 | 0.94 |
COL1A1 |
collagen, type I, alpha 1 |
13616 |
0.1 |
chr8_72841789_72841940 | 0.94 |
MSC |
musculin |
85161 |
0.08 |
chr2_151888848_151889130 | 0.94 |
AC023469.1 |
HCG1817310; Uncharacterized protein |
16299 |
0.25 |
chr9_124088136_124088287 | 0.94 |
GSN |
gelsolin |
649 |
0.65 |
chr15_49530588_49530739 | 0.93 |
ENSG00000243338 |
. |
39272 |
0.14 |
chr1_1207528_1208557 | 0.93 |
UBE2J2 |
ubiquitin-conjugating enzyme E2, J2 |
809 |
0.37 |
chr2_85403296_85403447 | 0.93 |
TCF7L1-IT1 |
TCF7L1 intronic transcript 1 (non-protein coding) |
10161 |
0.17 |
chr4_24804357_24804508 | 0.93 |
SOD3 |
superoxide dismutase 3, extracellular |
7347 |
0.3 |
chr7_112102135_112102289 | 0.92 |
IFRD1 |
interferon-related developmental regulator 1 |
825 |
0.67 |
chr7_5518471_5518623 | 0.91 |
ENSG00000238394 |
. |
6479 |
0.13 |
chr17_76593943_76594106 | 0.91 |
DNAH17 |
dynein, axonemal, heavy chain 17 |
20548 |
0.18 |
chr14_25372438_25372589 | 0.91 |
STXBP6 |
syntaxin binding protein 6 (amisyn) |
83830 |
0.1 |
chr2_145219345_145219496 | 0.91 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
31283 |
0.22 |
chr20_35905061_35905657 | 0.90 |
MANBAL |
mannosidase, beta A, lysosomal-like |
12682 |
0.18 |
chr10_75575525_75575677 | 0.90 |
RP11-574K11.5 |
|
2325 |
0.14 |
chr3_187606944_187607095 | 0.90 |
BCL6 |
B-cell CLL/lymphoma 6 |
143504 |
0.04 |
chr3_16177381_16177532 | 0.90 |
GALNT15 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
38700 |
0.19 |
chr8_69645584_69645735 | 0.90 |
ENSG00000239184 |
. |
37781 |
0.22 |
chr15_99069300_99069451 | 0.90 |
FAM169B |
family with sequence similarity 169, member B |
11764 |
0.29 |
chr4_86727557_86727760 | 0.89 |
ARHGAP24 |
Rho GTPase activating protein 24 |
21240 |
0.24 |
chr11_44267052_44267203 | 0.89 |
ALX4 |
ALX homeobox 4 |
64589 |
0.13 |
chr11_73990200_73990857 | 0.89 |
ENSG00000206913 |
. |
26931 |
0.14 |
chr2_36932543_36932694 | 0.89 |
VIT |
vitrin |
8598 |
0.25 |
chr3_53148225_53148737 | 0.89 |
RFT1 |
RFT1 homolog (S. cerevisiae) |
15946 |
0.17 |
chr22_30604075_30604921 | 0.89 |
RP3-438O4.4 |
|
1400 |
0.33 |
chr1_56796045_56796196 | 0.88 |
ENSG00000223307 |
. |
46970 |
0.2 |
chr6_133966238_133966389 | 0.88 |
RP3-323P13.2 |
|
122433 |
0.06 |
chr11_120419512_120419663 | 0.88 |
GRIK4 |
glutamate receptor, ionotropic, kainate 4 |
15556 |
0.22 |
chr15_90392195_90392442 | 0.88 |
ENSG00000264966 |
. |
1635 |
0.26 |
chr3_62145029_62145180 | 0.88 |
ENSG00000252184 |
. |
40920 |
0.2 |
chr22_19074070_19074357 | 0.88 |
AC004471.9 |
|
34829 |
0.09 |
chr12_26150271_26150549 | 0.87 |
RASSF8 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
2473 |
0.34 |
chr11_44243007_44243158 | 0.87 |
ALX4 |
ALX homeobox 4 |
88634 |
0.08 |
chr3_71456649_71456943 | 0.87 |
FOXP1 |
forkhead box P1 |
102885 |
0.07 |
chr5_111312819_111312970 | 0.87 |
NREP |
neuronal regeneration related protein |
266 |
0.93 |
chr10_79263751_79264179 | 0.87 |
ENSG00000199592 |
. |
82842 |
0.09 |
chr7_46598139_46598290 | 0.86 |
AC011294.3 |
Uncharacterized protein |
138506 |
0.05 |
chr9_16191463_16191614 | 0.86 |
C9orf92 |
chromosome 9 open reading frame 92 |
24359 |
0.27 |
chr10_74328138_74328289 | 0.86 |
ENSG00000238766 |
. |
8340 |
0.17 |
chr4_77580475_77580626 | 0.86 |
AC107072.2 |
|
21774 |
0.2 |
chr1_158972521_158972672 | 0.85 |
IFI16 |
interferon, gamma-inducible protein 16 |
2838 |
0.28 |
chr3_157184628_157184779 | 0.85 |
VEPH1 |
ventricular zone expressed PH domain-containing 1 |
28592 |
0.19 |
chr4_72116705_72116856 | 0.85 |
SLC4A4 |
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
63736 |
0.15 |
chr3_187121293_187121444 | 0.85 |
ENSG00000239093 |
. |
19735 |
0.21 |
chr6_112552839_112552990 | 0.85 |
RP11-506B6.6 |
|
4380 |
0.21 |
chr1_235909363_235909514 | 0.85 |
LYST |
lysosomal trafficking regulator |
6033 |
0.26 |
chr8_25075018_25075248 | 0.85 |
DOCK5 |
dedicator of cytokinesis 5 |
32753 |
0.19 |
chr20_38525369_38525520 | 0.85 |
ENSG00000263518 |
. |
206554 |
0.03 |
chr8_49341467_49342503 | 0.85 |
ENSG00000252710 |
. |
121395 |
0.06 |
chr14_53985712_53986006 | 0.84 |
RP11-547D23.1 |
|
365787 |
0.01 |
chr13_30229728_30229879 | 0.84 |
SLC7A1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
59978 |
0.15 |
chr3_186928854_186929005 | 0.84 |
RP11-208N14.4 |
|
3512 |
0.23 |
chr4_86758738_86758957 | 0.84 |
ARHGAP24 |
Rho GTPase activating protein 24 |
9801 |
0.27 |
chr2_224735945_224736096 | 0.84 |
AP1S3 |
adaptor-related protein complex 1, sigma 3 subunit |
33276 |
0.19 |
chr7_84178401_84178552 | 0.84 |
SEMA3A |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
56436 |
0.17 |
chr10_134388331_134388926 | 0.84 |
INPP5A |
inositol polyphosphate-5-phosphatase, 40kDa |
32802 |
0.18 |
chr1_110644690_110645263 | 0.84 |
UBL4B |
ubiquitin-like 4B |
10086 |
0.12 |
chr13_32460882_32461033 | 0.84 |
EEF1DP3 |
eukaryotic translation elongation factor 1 delta pseudogene 3 |
65760 |
0.13 |
chr13_38232414_38232565 | 0.84 |
POSTN |
periostin, osteoblast specific factor |
59508 |
0.15 |
chr10_120766900_120767051 | 0.83 |
ENSG00000215925 |
. |
1673 |
0.29 |
chr18_374431_374582 | 0.83 |
RP11-720L2.2 |
|
49910 |
0.15 |
chr20_4906603_4906754 | 0.83 |
SLC23A2 |
solute carrier family 23 (ascorbic acid transporter), member 2 |
26385 |
0.16 |
chr5_168359105_168359256 | 0.83 |
CTB-174D11.2 |
|
60825 |
0.13 |
chr6_34985069_34985220 | 0.83 |
TCP11 |
t-complex 11, testis-specific |
103678 |
0.06 |
chr19_19510818_19511425 | 0.83 |
CTB-184G21.3 |
|
2291 |
0.22 |
chr8_141001651_141001976 | 0.82 |
C8orf17 |
chromosome 8 open reading frame 17 |
58397 |
0.15 |
chr8_93072109_93072260 | 0.82 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
3007 |
0.39 |
chr7_92241505_92241788 | 0.82 |
FAM133B |
family with sequence similarity 133, member B |
21938 |
0.2 |
chr2_63991472_63991650 | 0.82 |
ENSG00000221085 |
. |
68892 |
0.11 |
chr10_102288134_102289261 | 0.82 |
HIF1AN |
hypoxia inducible factor 1, alpha subunit inhibitor |
132 |
0.88 |
chr16_81978946_81979245 | 0.82 |
ENSG00000260682 |
. |
16436 |
0.21 |
chr1_170646920_170647071 | 0.81 |
PRRX1 |
paired related homeobox 1 |
13917 |
0.28 |
chr5_111018255_111018529 | 0.81 |
ENSG00000253057 |
. |
37366 |
0.17 |
chr4_86727918_86728069 | 0.81 |
ARHGAP24 |
Rho GTPase activating protein 24 |
20905 |
0.25 |
chr14_89466929_89467242 | 0.81 |
TTC8 |
tetratricopeptide repeat domain 8 |
159213 |
0.04 |
chr9_109480327_109480478 | 0.81 |
ENSG00000200131 |
. |
38144 |
0.21 |
chr13_31390730_31391089 | 0.81 |
ALOX5AP |
arachidonate 5-lipoxygenase-activating protein |
81264 |
0.09 |
chr6_140400725_140400876 | 0.81 |
ENSG00000252107 |
. |
79031 |
0.12 |
chr20_7822496_7822647 | 0.81 |
HAO1 |
hydroxyacid oxidase (glycolate oxidase) 1 |
98550 |
0.08 |
chr12_31644520_31644671 | 0.81 |
DENND5B |
DENN/MADD domain containing 5B |
4241 |
0.2 |
chr6_132524156_132524307 | 0.80 |
ENSG00000265669 |
. |
87828 |
0.09 |
chr7_97880197_97881156 | 0.80 |
TECPR1 |
tectonin beta-propeller repeat containing 1 |
563 |
0.75 |
chr20_44407057_44407418 | 0.80 |
ENSG00000221046 |
. |
100 |
0.93 |
chr17_60074998_60075962 | 0.80 |
ENSG00000242398 |
. |
7868 |
0.17 |
chr11_114010396_114010654 | 0.80 |
ENSG00000221112 |
. |
52874 |
0.14 |
chr8_119761107_119761258 | 0.80 |
SAMD12 |
sterile alpha motif domain containing 12 |
126948 |
0.06 |
chr20_13377292_13377443 | 0.79 |
RP5-1077I2.3 |
|
151351 |
0.04 |
chr5_61762410_61762561 | 0.79 |
ENSG00000199279 |
. |
23482 |
0.18 |
chr4_39504952_39505103 | 0.79 |
UGDH |
UDP-glucose 6-dehydrogenase |
23150 |
0.13 |
chr10_105396701_105396852 | 0.79 |
SH3PXD2A |
SH3 and PX domains 2A |
24686 |
0.14 |
chr10_45491169_45491988 | 0.79 |
ZNF22 |
zinc finger protein 22 |
4345 |
0.14 |
chr1_115887502_115887653 | 0.79 |
NGF |
nerve growth factor (beta polypeptide) |
6720 |
0.28 |
chr8_95999659_95999889 | 0.79 |
NDUFAF6 |
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 |
6613 |
0.17 |
chr3_73776967_73777118 | 0.79 |
PDZRN3 |
PDZ domain containing ring finger 3 |
102951 |
0.07 |
chr1_224752371_224752739 | 0.78 |
RP11-100E13.1 |
|
51367 |
0.13 |
chr7_78102071_78102222 | 0.78 |
MAGI2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
298250 |
0.01 |
chr4_138586049_138586200 | 0.78 |
PCDH18 |
protocadherin 18 |
132476 |
0.06 |
chr2_145198431_145198780 | 0.78 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
10468 |
0.28 |
chr2_8558912_8559209 | 0.78 |
AC011747.7 |
|
256836 |
0.02 |
chr2_47747197_47748055 | 0.78 |
AC138655.4 |
|
7050 |
0.19 |
chr1_64688693_64688844 | 0.77 |
UBE2U |
ubiquitin-conjugating enzyme E2U (putative) |
2221 |
0.38 |
chr6_35994684_35994835 | 0.77 |
MAPK14 |
mitogen-activated protein kinase 14 |
729 |
0.63 |
chr10_80732581_80733347 | 0.77 |
ZMIZ1-AS1 |
ZMIZ1 antisense RNA 1 |
10813 |
0.3 |
chr9_89347792_89347943 | 0.77 |
GAS1 |
growth arrest-specific 1 |
214237 |
0.02 |
chr2_47432402_47432697 | 0.77 |
CALM2 |
calmodulin 2 (phosphorylase kinase, delta) |
28809 |
0.18 |
chr4_79483603_79483754 | 0.77 |
ANXA3 |
annexin A3 |
8604 |
0.26 |
chr7_127526528_127526679 | 0.77 |
SND1 |
staphylococcal nuclease and tudor domain containing 1 |
1362 |
0.57 |
chr19_18794913_18795747 | 0.77 |
CRTC1 |
CREB regulated transcription coactivator 1 |
842 |
0.53 |
chr11_78006328_78006479 | 0.77 |
RP11-452H21.1 |
|
29401 |
0.15 |
chr5_131604535_131604686 | 0.77 |
PDLIM4 |
PDZ and LIM domain 4 |
7468 |
0.16 |
chr7_152050844_152051077 | 0.77 |
ENSG00000253088 |
. |
48905 |
0.15 |
chr4_157869298_157869449 | 0.77 |
PDGFC |
platelet derived growth factor C |
22682 |
0.2 |
chr1_235117748_235117941 | 0.77 |
ENSG00000239690 |
. |
77911 |
0.1 |
chr2_145823231_145823382 | 0.77 |
ENSG00000253036 |
. |
269332 |
0.02 |
chr6_38227837_38227988 | 0.77 |
ENSG00000200706 |
. |
52862 |
0.16 |
chr15_49733509_49733731 | 0.77 |
FGF7 |
fibroblast growth factor 7 |
18163 |
0.22 |
chr17_28857993_28858144 | 0.76 |
TBC1D29 |
TBC1 domain family, member 29 |
26062 |
0.13 |
chr3_124880202_124880413 | 0.76 |
ENSG00000264986 |
. |
9911 |
0.2 |
chr1_110913277_110913428 | 0.76 |
RP5-1074L1.4 |
|
576 |
0.64 |
chr7_7479175_7479326 | 0.76 |
COL28A1 |
collagen, type XXVIII, alpha 1 |
2184 |
0.43 |
chr16_72289656_72289807 | 0.76 |
PMFBP1 |
polyamine modulated factor 1 binding protein 1 |
78954 |
0.09 |
chr9_5921256_5921407 | 0.75 |
MLANA |
melan-A |
30409 |
0.15 |
chr5_10526426_10526663 | 0.75 |
RP11-1C1.5 |
Uncharacterized protein |
17238 |
0.17 |
chr11_114156423_114156641 | 0.75 |
NNMT |
nicotinamide N-methyltransferase |
10015 |
0.23 |
chr3_45127227_45127378 | 0.75 |
ENSG00000252410 |
. |
51222 |
0.11 |
chr4_77657284_77657435 | 0.75 |
RP11-359D14.2 |
|
22268 |
0.2 |
chr3_137781202_137781404 | 0.75 |
DZIP1L |
DAZ interacting zinc finger protein 1-like |
5179 |
0.24 |
chr15_91223450_91223638 | 0.75 |
RP11-387D10.3 |
|
19574 |
0.14 |
chrX_149898940_149899091 | 0.75 |
MTMR1 |
myotubularin related protein 1 |
11866 |
0.27 |
chr20_48889352_48889575 | 0.75 |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
82087 |
0.08 |
chr9_83646594_83646895 | 0.75 |
ENSG00000221581 |
. |
297500 |
0.01 |
chr2_153393851_153394002 | 0.75 |
FMNL2 |
formin-like 2 |
82166 |
0.11 |
chr3_148676412_148676563 | 0.75 |
RP11-680B3.2 |
|
1412 |
0.46 |
chr5_178698233_178698384 | 0.75 |
ADAMTS2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
74123 |
0.11 |
chr2_109825380_109825531 | 0.75 |
ENSG00000264934 |
. |
67411 |
0.12 |
chr12_68714119_68714270 | 0.75 |
MDM1 |
Mdm1 nuclear protein homolog (mouse) |
11622 |
0.26 |
chr9_79433019_79433170 | 0.74 |
PCA3 |
prostate cancer antigen 3 (non-protein coding) |
53742 |
0.16 |
chr11_47628746_47628950 | 0.74 |
ENSG00000223187 |
. |
7698 |
0.09 |
chr8_12965869_12966020 | 0.74 |
DLC1 |
deleted in liver cancer 1 |
7809 |
0.25 |
chr8_131303878_131304176 | 0.74 |
ASAP1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
44739 |
0.19 |
chr7_44140390_44140770 | 0.74 |
AEBP1 |
AE binding protein 1 |
3380 |
0.11 |
chr5_36684794_36684945 | 0.74 |
CTD-2353F22.1 |
|
40406 |
0.19 |
chr3_171547228_171547513 | 0.74 |
TMEM212 |
transmembrane protein 212 |
13769 |
0.18 |
chr14_68864676_68864966 | 0.74 |
RAD51B |
RAD51 paralog B |
13406 |
0.29 |
chr8_118837908_118838059 | 0.74 |
EXT1 |
exostosin glycosyltransferase 1 |
284670 |
0.01 |
chr1_164717949_164718100 | 0.74 |
PBX1 |
pre-B-cell leukemia homeobox 1 |
24125 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.4 | 1.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 0.4 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) venous blood vessel development(GO:0060841) |
0.3 | 1.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 1.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 1.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.3 | 0.5 | GO:0010193 | response to ozone(GO:0010193) |
0.3 | 0.8 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.3 | 0.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.7 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.7 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.2 | 0.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.7 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 0.9 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 1.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.9 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.2 | 1.2 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.2 | 0.8 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.6 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.6 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.2 | 0.4 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.5 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.2 | 0.5 | GO:0071436 | sodium ion export(GO:0071436) |
0.2 | 0.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.7 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 0.2 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 0.7 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.2 | 0.7 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.2 | 0.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.5 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.2 | 0.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 0.5 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.2 | 0.6 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 1.9 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.2 | 0.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.6 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.4 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.6 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.7 | GO:0010664 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.3 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.3 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.1 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.5 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.4 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.8 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.4 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 1.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 2.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.4 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.5 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.5 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.3 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.1 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.1 | GO:1903170 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 0.4 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.6 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.4 | GO:0090030 | regulation of steroid hormone biosynthetic process(GO:0090030) |
0.1 | 0.3 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 0.5 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.3 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.1 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.6 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.3 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.2 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.1 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.1 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.2 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.3 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.1 | 0.3 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.8 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.2 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.4 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.2 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.1 | 0.2 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.1 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.3 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.7 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 0.1 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.2 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.1 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.1 | 0.5 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.1 | GO:0014848 | urinary tract smooth muscle contraction(GO:0014848) |
0.1 | 0.3 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.3 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.3 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.1 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.3 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0061082 | myeloid leukocyte cytokine production(GO:0061082) |
0.1 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.2 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.3 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.1 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.7 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.1 | 0.2 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.1 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.8 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.1 | 0.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.1 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.2 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.3 | GO:0044068 | modulation by virus of host process(GO:0019054) modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.3 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.1 | 0.3 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.2 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 1.2 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.0 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.3 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.6 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.3 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.0 | GO:0071028 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.6 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.3 | GO:0071450 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.0 | GO:0072143 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.0 | 0.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) regulation of lamellipodium organization(GO:1902743) |
0.0 | 0.3 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.0 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.1 | GO:0001759 | organ induction(GO:0001759) regulation of organ formation(GO:0003156) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.3 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.7 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.1 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.0 | 0.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.2 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.1 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.0 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 0.2 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.3 | GO:0021772 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.1 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.0 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.3 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.0 | 0.2 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.3 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.0 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.0 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.1 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.1 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.3 | GO:0007622 | rhythmic behavior(GO:0007622) |
0.0 | 0.0 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.0 | 0.4 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.2 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.1 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.2 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.1 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.3 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.6 | GO:0044247 | glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.2 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.1 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
0.0 | 0.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.1 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.3 | GO:0019359 | NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.0 | 0.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.2 | GO:0042116 | macrophage activation(GO:0042116) |
0.0 | 0.1 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.0 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.0 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.2 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.0 | 0.0 | GO:0032604 | granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) |
0.0 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.4 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.0 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) negative regulation of cation transmembrane transport(GO:1904063) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.0 | GO:0043369 | alpha-beta T cell lineage commitment(GO:0002363) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:0003207 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.8 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.0 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.1 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.0 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.4 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.0 | 0.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 0.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.0 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.0 | 0.1 | GO:0090175 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.0 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.0 | GO:0010224 | response to UV-B(GO:0010224) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.1 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.0 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.3 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.0 | GO:0060251 | regulation of glial cell proliferation(GO:0060251) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.2 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.1 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
0.0 | 0.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.0 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 0.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.0 | 0.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.0 | GO:0060426 | lung vasculature development(GO:0060426) |
0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.6 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.0 | 0.1 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.1 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.0 | GO:0010829 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.0 | 0.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 0.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.0 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.0 | GO:0043954 | cellular component maintenance(GO:0043954) |
0.0 | 0.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.1 | GO:0098764 | meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.1 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.0 | GO:0032692 | negative regulation of interleukin-1 production(GO:0032692) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.1 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 0.1 | GO:0030878 | thyroid gland development(GO:0030878) |
0.0 | 0.1 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.2 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.0 | 0.0 | GO:0015825 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
0.0 | 0.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0044065 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) regulation of respiratory system process(GO:0044065) |
0.0 | 0.0 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.1 | GO:0071326 | cellular response to carbohydrate stimulus(GO:0071322) cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.0 | 0.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.0 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.2 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.1 | GO:0014075 | response to amine(GO:0014075) |
0.0 | 0.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.0 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.0 | GO:0046040 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 0.6 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 1.2 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.2 | 1.0 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 1.8 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.2 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.1 | 0.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.8 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.4 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.9 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.9 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.1 | GO:0043230 | extracellular organelle(GO:0043230) |
0.1 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.5 | GO:0043256 | laminin complex(GO:0043256) |
0.1 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 2.4 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.2 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.2 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.2 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.2 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.0 | 1.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.1 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.1 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 6.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 1.2 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 1.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 1.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.0 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.2 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 1.6 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.6 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 5.4 | GO:0044421 | extracellular region part(GO:0044421) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.4 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.3 | 0.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 1.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 0.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 1.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.8 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 0.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.6 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.7 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.8 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.4 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 1.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.6 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.7 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.7 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.6 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.3 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 3.4 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.4 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.4 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.1 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.2 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 1.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.2 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.4 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.1 | 0.3 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 4.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 1.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 1.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.1 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.2 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.1 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.5 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.2 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.6 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.4 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.4 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.2 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.2 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.4 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.5 | GO:1990782 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.4 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 1.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 1.1 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.4 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 1.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.0 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 2.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.5 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.2 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.2 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.0 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.0 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.0 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.0 | 0.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.0 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.0 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 6.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 1.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.0 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 1.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 5.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 6.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 3.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.3 | 2.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 6.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 0.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 1.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 1.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.8 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.5 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.0 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.1 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.0 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.2 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |